PL2056799T3 - Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi - Google Patents

Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi

Info

Publication number
PL2056799T3
PL2056799T3 PL07841303T PL07841303T PL2056799T3 PL 2056799 T3 PL2056799 T3 PL 2056799T3 PL 07841303 T PL07841303 T PL 07841303T PL 07841303 T PL07841303 T PL 07841303T PL 2056799 T3 PL2056799 T3 PL 2056799T3
Authority
PL
Poland
Prior art keywords
progression
compositions
treating
methods
preventing glaucoma
Prior art date
Application number
PL07841303T
Other languages
English (en)
Inventor
Stephen P Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of PL2056799T3 publication Critical patent/PL2056799T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07841303T 2006-08-31 2007-08-24 Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi PL2056799T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84143706P 2006-08-31 2006-08-31
PCT/US2007/076706 WO2008027796A2 (en) 2006-08-31 2007-08-24 Compositions and methods for treating or preventing glaucoma or progression thereof
EP07841303.6A EP2056799B1 (en) 2006-08-31 2007-08-24 Compositions and methods for treating or preventing glaucoma or progression thereof

Publications (1)

Publication Number Publication Date
PL2056799T3 true PL2056799T3 (pl) 2014-01-31

Family

ID=39077201

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07841303T PL2056799T3 (pl) 2006-08-31 2007-08-24 Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi

Country Status (16)

Country Link
US (1) US20080058373A1 (pl)
EP (2) EP2397140A1 (pl)
JP (1) JP2010502635A (pl)
KR (1) KR20090050091A (pl)
CN (1) CN101528208A (pl)
AU (1) AU2007289373A1 (pl)
BR (1) BRPI0716087A2 (pl)
CA (1) CA2661607C (pl)
DK (1) DK2056799T3 (pl)
ES (1) ES2425178T3 (pl)
MX (1) MX2009002228A (pl)
PL (1) PL2056799T3 (pl)
PT (1) PT2056799E (pl)
SI (1) SI2056799T1 (pl)
TW (1) TWI336701B (pl)
WO (1) WO2008027796A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090042936A1 (en) * 2007-08-10 2009-02-12 Ward Keith W Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
US20090087443A1 (en) * 2007-09-27 2009-04-02 Bartels Stephen P Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
BRPI0819175A2 (pt) * 2007-11-05 2015-05-05 Bausch & Lomb Composição farmacêutica oftálmica, e, método para proporcionar disponibilidade estendida de um componente farmacêutico em um ambiente ocular de um indivíduo, e, uso de pelo menos um componente farmacêutico, pelo menos um material imiscível em água e opcionalmente um composto modificador de viscosidade
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
RU2473363C1 (ru) * 2012-02-24 2013-01-27 Илья Александрович Марков Противовирусное средство - глазные капли
RU2561046C1 (ru) * 2014-10-30 2015-08-20 Илья Александрович Марков Гелеобразные глазные капли для лечения воспалительных, аллергических, бактериальных, вирусных, травматических и дистрофических заболеваний глаз
CA3123490A1 (en) 2019-01-22 2020-07-30 Akribes Biomedical Gmbh Selective glucocorticoid receptor modifiers for treating impaired skin wound healing

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6242196B1 (en) 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
AU4713499A (en) 1998-06-27 2000-01-17 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
KR100919234B1 (ko) 2001-07-03 2009-09-30 가나이 히로아키 관 이음용 그립 링의 제조 방법 및 그 관이음용 그립 링의 제조 장치
DE60309829T2 (de) * 2002-01-14 2007-09-13 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
US7268152B2 (en) * 2002-03-26 2007-09-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
MXPA04009329A (es) * 2002-03-26 2005-01-25 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos.
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004005229A1 (en) * 2002-07-08 2004-01-15 Pfizer Products Inc. Modulators of the glucocorticoid receptor
JP4373926B2 (ja) * 2003-01-03 2009-11-25 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド １−プロパノール及び１−プロピルアミン誘導体ならびにグルココルチコイドリガンドとしての使用
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7537788B2 (en) * 2003-07-25 2009-05-26 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
JP2007530541A (ja) * 2004-03-22 2007-11-01 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメチックスとしてのα−トリフルオロメチルアルコール又はアミン
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7417056B2 (en) * 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
CN101522187A (zh) * 2006-08-07 2009-09-02 博士伦公司 用于治疗、减轻、改善或缓解后段眼病的组合物和方法

Also Published As

Publication number Publication date
EP2056799B1 (en) 2013-07-31
CN101528208A (zh) 2009-09-09
DK2056799T3 (da) 2013-10-28
US20080058373A1 (en) 2008-03-06
MX2009002228A (es) 2009-04-17
TWI336701B (en) 2011-02-01
AU2007289373A1 (en) 2008-03-06
BRPI0716087A2 (pt) 2013-10-01
WO2008027796A2 (en) 2008-03-06
CA2661607C (en) 2012-06-26
KR20090050091A (ko) 2009-05-19
EP2056799A2 (en) 2009-05-13
JP2010502635A (ja) 2010-01-28
PT2056799E (pt) 2013-11-06
EP2397140A1 (en) 2011-12-21
ES2425178T3 (es) 2013-10-11
CA2661607A1 (en) 2008-03-06
TW200817378A (en) 2008-04-16
WO2008027796A3 (en) 2008-09-12
SI2056799T1 (sl) 2013-11-29

Similar Documents

Publication Publication Date Title
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
IL257681A (en) Methods and compositions for the treatment of cancer
IL193014A0 (en) Methods and compositions for treating schizophrenia
SI2374472T1 (sl) Sestavki in postopki za zdravljenje oftalmoloških motenj
HK1134679A1 (zh) 用於治療感染的組合物和方法
HK1121952A1 (en) Methods and compositions for treating conditions
EP2083862A4 (en) COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS
EP2010117A4 (en) COMPOSITIONS AND METHODS FOR ADHESION INHIBITION
EP1899480A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
EP2124985A4 (en) METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS
PL2529626T3 (pl) Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy
ZA200708575B (en) Methods and compositions for treating or preventing cancer
EP2015765A4 (en) METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
EP2069391A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING EYE DRYING
SI2056799T1 (sl) Sestavki in postopki za zdravljenje ali preprečevanje glavkoma ali njegovega napredovanja
GB0718918D0 (en) Compositions and methods for treating skin conditions
HK1129596A1 (en) Methods and compositions for treating disease
EP1959982A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND / OR TREATING PANCREATITIS
PL2374472T3 (pl) Kompozycje i sposoby leczenia zaburzeń okulistycznych
EP2094279A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
EP1993612A4 (en) COMPOSITIONS AND METHODS FOR TREATING COGNITIVE INTERFERENCE
GB0617280D0 (en) Compositions and methods for the treatment of neurological damage
ZA201001779B (en) Compositions and methods for treating collagen-mediated diseases
EP2068629A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER